Clinical Trials · NCT02953665
Safety and Efficacy of Liraglutide in Parkinson's Disease
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Cedars-Sinai Medical Center
- Enrollment
- 63
- Start date
- Apr 2017
- Locations
- 1 site, United States
- Primary endpoint
- Change in Unified Parkinson's Disease Rating Scale (UPDRS Part III Motor Examination) During "OFF" Time From Baseline to the End of Double-Blind Maintenance Period